New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

Updated on: January 11,2024

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

Updated on:January 11,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on: January 13,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on:January 13,2024

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

Updated on: March 20,2024

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

Updated on:March 20,2024

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on: March 01,2024

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on:March 01,2024

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Updated on: June 01,2024

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Updated on:June 01,2024

Researchers find new, safer treatment for serious side effect of bone marrow transplant

by The Mount Sinai HospitalHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaResear

Updated on: January 30,2024

Researchers find new, safer treatment for serious side effect of bone marrow transplant

by The Mount Sinai HospitalHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaResear

Updated on:January 30,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainResearchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change t

Updated on: January 10,2024

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainResearchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change t

Updated on:January 10,2024

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on: December 28,2023

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on:December 28,2023

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on: September 07,2024

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on:September 07,2024

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on: March 12,2024

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on:March 12,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on: March 01,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on:March 01,2024